Infections, Human Immunodeficiency Virus and Hepatitis
2 competing products in clinical development for Infections, Human Immunodeficiency Virus and Hepatitis.
Pipeline by Phase
Phase 12
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Dolutegravir + Rlipivirine + GSK1265744 | Shionogi | Phase 1 | Completed | 29 |
| Dolutegravir + Methadone | Shionogi | Phase 1 | Completed | 29 |